We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBON icon
6501
VanEck China Bond ETF
CBON
$26.3M
$25K ﹤0.01%
1,104
-345
-24% -$8.18K
CECO icon
6502
Ceco Environmental
CECO
$4.04B
$25K ﹤0.01%
4,052
-549
-12% -$3.02K
CRWS icon
6503
Crown Crafts
CRWS
$32.1M
$25K ﹤0.01%
4,477
-16,510
-79% -$96K
FTDS icon
6504
First Trust Dividend Strength ETF
FTDS
$39M
$25K ﹤0.01%
730
KALV
6505
DELISTED
KalVista Pharmaceuticals
KALV
$25K ﹤0.01%
3,114
+2,969
+2,048% +$26.2K
LQDT icon
6506
Liquidity Services
LQDT
$1.17B
$25K ﹤0.01%
3,746
+1,804
+93% +$11K
NTWK icon
6507
NetSol Technologies
NTWK
$50.8M
$25K ﹤0.01%
+4,447
New +$23.4K
OPOF
6508
DELISTED
Old Point Financial
OPOF
$25K ﹤0.01%
850
+249
+41% +$6.73K
SNT
6509
Senstar Technologies
SNT
$46.2M
$25K ﹤0.01%
4,637
+1,637
+55% +$8.9K
UYG icon
6510
ProShares Ultra Financials
UYG
$861M
$25K ﹤0.01%
638
+578
+963% +$24K
WHLRD
6511
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$66.2M
$25K ﹤0.01%
1,345
+401
+42% +$6.79K
CURO
6512
DELISTED
CURO Group Holdings Corp.
CURO
$25K ﹤0.01%
986
-377
-28% -$8.28K
KFYP
6513
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
$25K ﹤0.01%
+736
New +$25.1K
AZRE
6514
DELISTED
Azure Power Global Limited
AZRE
$25K ﹤0.01%
1,759
+1,000
+132% +$14.9K
PBEE
6515
DELISTED
Invesco PureBeta FTSE Emerging Markets ETF
PBEE
$25K ﹤0.01%
1,015
IRL
6516
DELISTED
NEW IRELAND FUND INC
IRL
$25K ﹤0.01%
2,100
-451
-18% -$5.42K
HZN
6517
DELISTED
Horizon Global Corporation
HZN
$25K ﹤0.01%
4,165
-38,809
-90% -$268K
HTGM
6518
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$25K ﹤0.01%
42
+39
+1,300% +$25.4K
AVLR
6519
DELISTED
Avalara, Inc.
AVLR
$25K ﹤0.01%
+475
New +$22.6K
LMRKN
6520
DELISTED
Landmark Infrastructure Partners LP 7% Series C Fltg/Fxd Perpetual Conv Preferred Stock
LMRKN
$25K ﹤0.01%
+1,073
New +$25.1K
TDACU
6521
DELISTED
Trident Acquisitions Corp. Units
TDACU
$25K ﹤0.01%
+2,494
New +$25.1K
TAPR
6522
DELISTED
iPath Inverse US Treasury Composite ETN
TAPR
$25K ﹤0.01%
66
FOMX
6523
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$25K ﹤0.01%
4,936
+3,936
+394% +$20.3K
SRCI
6524
DELISTED
SRC Energy Inc
SRCI
$25K ﹤0.01%
2,259
-15,288
-87% -$171K
MBTF
6525
DELISTED
MBT Financial Corporation
MBTF
$25K ﹤0.01%
2,377
+2,307
+3,296% +$24.3K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.